These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 25517714)
1. Multidrug-resistant tuberculosis and bedaquiline. Diacon AH; Lounis N; Dannemann B N Engl J Med; 2014 Dec; 371(25):2436. PubMed ID: 25517714 [No Abstract] [Full Text] [Related]
2. Multidrug-resistant tuberculosis and bedaquiline. Salfinger M; Somoskövi A N Engl J Med; 2014 Dec; 371(25):2435-6. PubMed ID: 25517715 [No Abstract] [Full Text] [Related]
3. FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis. Cox E; Laessig K N Engl J Med; 2014 Aug; 371(8):689-91. PubMed ID: 25140952 [No Abstract] [Full Text] [Related]
4. Rapid emergence of Veziris N; Bernard C; Guglielmetti L; Le Du D; Marigot-Outtandy D; Jaspard M; Caumes E; Lerat I; Rioux C; Yazdanpanah Y; Tiotiu A; Lemaitre N; Brossier F; Jarlier V; Robert J; Sougakoff W; Aubry A; ; Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28182568 [No Abstract] [Full Text] [Related]
5. Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment. de Vos M; Ley SD; Wiggins KB; Derendinger B; Dippenaar A; Grobbelaar M; Reuter A; Dolby T; Burns S; Schito M; Engelthaler DM; Metcalfe J; Theron G; van Rie A; Posey J; Warren R; Cox H N Engl J Med; 2019 May; 380(22):2178-2180. PubMed ID: 31141643 [No Abstract] [Full Text] [Related]
6. Current issues with the use of bedaquiline. Kakkar AK; Dahiya N Ann Pharmacother; 2014 May; 48(5):666. PubMed ID: 24519480 [No Abstract] [Full Text] [Related]
7. Bedaquiline and delamanid in combination for treatment of drug-resistant tuberculosis. Mohr E; Ferlazzo G; Hewison C; De Azevedo V; Isaakidis P Lancet Infect Dis; 2019 May; 19(5):470. PubMed ID: 31034392 [No Abstract] [Full Text] [Related]
8. Bedaquiline for the treatment of drug-resistant tuberculosis. Bélard S; Heuvelings CC; Janssen S; Grobusch MP Expert Rev Anti Infect Ther; 2015 May; 13(5):535-53. PubMed ID: 25797824 [TBL] [Abstract][Full Text] [Related]
10. Initial experience of bedaquiline use in a series of drug-resistant tuberculosis patients from India. Udwadia ZF; Amale RA; Mullerpattan JB Int J Tuberc Lung Dis; 2014 Nov; 18(11):1315-8. PubMed ID: 25299863 [TBL] [Abstract][Full Text] [Related]
12. Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon. Andres S; Merker M; Heyckendorf J; Kalsdorf B; Rumetshofer R; Indra A; Hofmann-Thiel S; Hoffmann H; Lange C; Niemann S; Maurer FP Am J Respir Crit Care Med; 2020 Jun; 201(12):1564-1568. PubMed ID: 32053752 [No Abstract] [Full Text] [Related]
13. Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis. Achar J; Hewison C; Cavalheiro AP; Skrahina A; Cajazeiro J; Nargiza P; Herboczek K; Rajabov AS; Hughes J; Ferlazzo G; Seddon JA; du Cros P Emerg Infect Dis; 2017 Oct; 23(10):1711-3. PubMed ID: 28758889 [TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant tuberculosis and culture conversion with bedaquiline. Diacon AH; Pym A; Grobusch MP; de los Rios JM; Gotuzzo E; Vasilyeva I; Leimane V; Andries K; Bakare N; De Marez T; Haxaire-Theeuwes M; Lounis N; Meyvisch P; De Paepe E; van Heeswijk RP; Dannemann B; N Engl J Med; 2014 Aug; 371(8):723-32. PubMed ID: 25140958 [TBL] [Abstract][Full Text] [Related]
15. Bedaquiline (Sirturo) for multidrug-resistant tuberculosis. Med Lett Drugs Ther; 2013 Aug; 55(1423):66-8. PubMed ID: 23959388 [No Abstract] [Full Text] [Related]
16. Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis. Bloemberg GV; Keller PM; Stucki D; Trauner A; Borrell S; Latshang T; Coscolla M; Rothe T; Hömke R; Ritter C; Feldmann J; Schulthess B; Gagneux S; Böttger EC N Engl J Med; 2015 Nov; 373(20):1986-8. PubMed ID: 26559594 [TBL] [Abstract][Full Text] [Related]
17. Bedaquiline: a novel antitubercular drug for multidrug-resistant tuberculosis. Nagabushan H; Roopadevi HS J Postgrad Med; 2014; 60(3):300-2. PubMed ID: 25121373 [TBL] [Abstract][Full Text] [Related]
18. Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline. Pontali E; D'Ambrosio L; Centis R; Sotgiu G; Migliori GB Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331046 [No Abstract] [Full Text] [Related]
19. Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis? Guglielmetti L; Le Dû D; Veziris N; Caumes E; Marigot-Outtandy D; Yazdanpanah Y; Robert J; Fréchet-Jachym M; Eur Respir J; 2016 Aug; 48(2):582-5. PubMed ID: 27338196 [No Abstract] [Full Text] [Related]
20. The use of bedaquiline to treat patients with multidrug-resistant tuberculosis and end-stage renal disease: A case report. Park S; Lee KM; Kim I; Mok J Int J Infect Dis; 2018 Nov; 76():88-90. PubMed ID: 30244076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]